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Anemia is a major public health problem worldwide 
and is often ignored in both developed and 
developing  countries.   Preschool   children,  pregnant 
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women and adolescents constitute vulnerable group 
of anemia. Anemia may result in reduced growth and 
increased morbidity. Further, it causes important 
health and social and economic consequences, 
hampers cognitive development, reduce physical 
work capacity. 
Adolescence is a vulnerable period in the human life 
cycle for the development of nutritional anemia which 
affects both sexes and all age group. Particularly in 
developing countries, among adolescents, girls 
constitute most vulnerable for anemia. Adolescence is 
the formative period of life where maximum amount 
of physical, psychological and behavioral change takes 
place. 
The prevalence of anemia among adolescent is 27% in 
developing country and 6% in developed country.
[1]
 A 
A B S T R A C T  
Background: Anemia in adolescent girls possess greatest burden on their health as it leads to poor 
cognitive development, poor reproductive health and if not treated may lead to intrauterine growth 
retardation in their developing fetus. The prevalence of anemia among adolescent is 27% in 
developing country and 6% in developed country. By looking at the magnitude of the problem, an 
Ayurveda drug Vajravatakmandura has been selected for the study and the present study was 
undertaken to evaluate the efficacy of the trial drug in iron deficiency anemia in adolescent 
girls. Material and methods: 100 subjects satisfying inclusion and exclusion criteria were selected 
and were randomly divided in two groups. In group A, the trial drug Vajravatakmaņdura was 
administered and in group B, IFA tablets were given for two month of duration with follow up at every 
fortnight. Result: Both the trial and control groups showed extremely significant result over 
subjective parameters. Trial drug Vajravatakmaņdura in group A was found more effective over the 
subjective parameters - weakness, palpitation, pallor and loss of appetite with % gain of 39.77%, 
39.39%, 39.17%, 38.09% respectively. Statistical analysis between before and after treatment 
findings of objective parameters, extremely significant (P<0.0001) improvement was found in both 
groups in all parameters, except for RBC count in group A, which was significant. No adverse effects 
were reported during entire period of study by any of the patients in trial group treated with trial 
drug. Conclusion: The trial drug “Vajravatakmandura” is effective, safe and palatable for the 
management of iron deficiency anemia in adolescent girls. 
Key words: Anemia, Adolescent Girls, Iron Deficiency, Pandu Roga, Ayurveda. 
Rashmi Pareek et.al. Study to Evaluate efficacy of Vajravatakmandura in Iron Deficiency.    
ISSN: 2456-3110                                                    ORIGINAL ARTICLE Jan-Feb 2018 
 
Journal of Ayurveda and Integrated Medical Sciences | Jan - Feb  2018 | Vol. 3 | Issue 1 27 
 
study which was conducted in the rural areas of 
Tamilnadu revealed that the prevalence of the anemia 
among the adolescent girls as 44.8%.
[2]
 Another study, 
conducted among the girls, who belonged to the low 
income families in Lucknow, revealed that 67% of the 
adolescent girls were anemic.
[3]
 
Anemia in adolescent girls possess greatest burden on 
their health as it leads to poor cognitive development, 
poor reproductive health and if not treated may lead 
to intrauterine growth retardation in their developing 
fetus. The Government of India has launched National 
Anemia Control Programme, to prevent and control 
anaemia in children and adolescents. Iron and folic 
acid (IFA) tablets are supplied free to all children, 
adolescents and pregnant mothers by means of 
dispensaries and ASHA workers. But the problem is 
still persisting because of many issues like - poor 
palatability, intolerance to the drug used, poor 
absorption of the drugs used, constipation, 
discoloration of stool, unpleasant odor etc. result in 
poor compliance and therefore non adherence to the 
therapy which finally results in poor improvement. 
Also the taste and side effects of presently available 
drugs are not suited to children and adolescence.  
By looking at the magnitude of the problem greater 
efforts are needed to develop and implement 
program both to prevent and control anemia with a 
better and palatable drug with good taste and easy 
administration. In Ayurveda, symptoms of Iron 
deficiency anemia are described under Pandu Roga. In 
Ayurveda, a lot of different types of formulations are 
available for the management of Pandu Roga 
(anaemia). With this view, the present study entitled 
“A Study to Evaluate Efficacy of Vajravatakmaņdura in 
Iron Deficiency Anemia in Adolescent Girls: A 
Randomised Control Trial” was conducted.  
OBJECTIVES OF THE STUDY  
The present research work was undertaken with 
following main objectives:  
1. To evaluate the clinical efficacy of an Ayurvedic 
compound “Vajravatakmandura” in the 
management of Iron Deficiency Anemia in 
adolescent girls. 
2. To establish clinical safety of the study drug. 
MATERIAL AND METHODS 
 Study type: Randomized Controlled Trial  
 Masking: Open label  
 Control: Controlled (IFA Tablets)  
 Duration: 8 weeks  
 End point: Safety and Efficacy  
 No. of groups: Two  
 Sample size: 100  
TIMELINES 
 Total trial period: 8 weeks  
 Washout/Preparatory Period: 4 weeks (if 
required)  
 Follow-Up period: 4 weeks 
Selection of Cases 
Source: 
Female subjects attending the O.P.D. and I.P.D. of 
Kaumarabhritya, PG Department of National Institute 
of Ayurveda, Jaipur and from various schools situated 
in Jaipur by survey method were screened for the 
present study. 
Age Group 
Adolescent girls of 12-15 years of age were selected 
for the study. 
Grouping of patients 
Total 100 cases will be divided into two groups (50 in 
each) 
Group A: Trial drug (Vajravatakmandura) (50 cases) 
Group B: Control (IFA Tablets) (50 cases) 
Inclusion Criteria  
1. Adolescent girls aged between 12-15years. 
2. Adolescent girls with iron deficiency anemia (Hb 
8g.-12g.%). 
Exclusion criteria 
1. Adolescent girls suffering from major systemic 
illness necessitating long term treatment. 
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2. Adolescent girls with evidence of malignancy. 
3. Adolescent girls with concurrent serious hepatic 
dysfunction (defined as AST and/or ALT>3 times 
of the upper normal limit) or renal dysfunction 
(defined as S. creatinine>1.2mg/dl) uncontrolled 
pulmonary dysfunction (asthmatic and COPD 
subjects) 
4. Co-morbidity like TB, UTI and bleeding disorders 
etc. 
5. H/o hypersensitivity to any of the trial drug or 
their ingredients. 
6. Adolescent girls who have completed 
participation in any other clinical trial during the 
past six months. 
Assessment Criteria 
For assessment of the efficacy of the trial therapy, 
following parameters were adopted- 
 Subjective: Based on clinical features of anemia 
according to both modern and Ayurveda 
parameters on the basis of presenting features on 
four point scale. 
 Objective: Laboratory findings were assessed 
before and after treatment. Hb%, CBC, PBS, Stool 
routine and microscopic. 
Adverse effects 
To rule out the possible adverse effects of the trial 
drug, record of information was maintained on every 
follow-up i.e. gastric irritation, gastric upset, 
constipation, diarrhoea, teeth discoloration, other 
untoward effect if any. 
Study Drug : Vajravatakmaņdura
[4] 
Vajravatakmandura is an Ayurveda herbo-mineral 
formulation for the treatment of Panduroga. The trial 
drug Vajravatakmaņdura was prepared in the 
attached Pharmacy of the institute. The compound 
was modified to make it in tablet form for easy 
administration to adolescent girls. Takra (butter milk) 
as mentioned in original text was taken as vehicle of 
the trial drug.  (Schedule of the treatment is as shown 
in Table 1) 
Table 1: Showing schedule of the treatment 
 Group A (n=50) Group B (n=50) 
Trial drug 
(Vajravatakmaņdura ) 
Control drug (IFA 
tablets) 
Dose 500mg in two divided 
doses 
100 mg elemental iron 




Route  Oral (After meals) Oral (After meals) 
Anupana Butter milk Water 
Duration 8 weeks 8 weeks 
IEC Approval 
Institutional Ethics committee’s approval was taken to 
conduct the clinical trial. Study was approved by IEC, 
National Institute of Ayurveda, Jaipur, and order no. - 
F10 (5)/EC/2014 /7220. A voluntary signed, witnessed 
informed consent was obtained from the participant / 
parents/ guardians prior to the start of clinical trial. 
The trial was also registered in CTRI with registration 
number CTRI/2017/10/010037. 
OBSERVATIONS 
In present study, loss of appetite, improper digestion, 
pallor were commonly observed premonitory 
symptoms, while falling of hairs, weakness in feet, 
lack of interest in routine activities were most 
commonly observed symptoms. While in demographic 
study fatigue was most prevalent symptom which was 
observed during the survey. (Table 2) 
Table 2: Showing common observations of clinical 
study 






No % No % No % 
Severity of Mild (Hb<12- 36 72 38 76 74 74 
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09 18 08 16 17 17 
Severe 
(Hb<8%) 
05 10 04 08 09 09 
Age Group (in 
years) 
12 to  <13 13 26 15 30 28 28 
13 to  <14 18 36 17 34 35 35 
14 to  <15 19 38 18 36 37 37 
Menarche Achieved 32 64 28 56 60 60 
Not achieved 18 36 22 44 40 40 
Religion Hindu 22 44 30 60 52 52 
Muslim 28 56 20 40 48 48 
Others 00 00 00 00 00 00 
Habitat Urban Area 44 88 48 96 92 92 
Rural Area 06 12 02 04 08 08 
Economic 
status 
Higher 00 00 01 01 01 01 
Upper 
Middle 
10 20 07 14 17 17 
Lower Middle 26 52 31 62 57 57 





11 22 14 28 25 25 
Incomplete 08 16 06 12 14 14 
Complete 10 20 07 14 17 17 
Unknown 21 42 23 46 44 44 
Diet Vegetarian 20 40 22 44 42 42 
Mixed 30 60 28 56 58 58 
Weight Average 32 64 30 60 62 62 
Under weight 18 36 19 38 37 37 
Over weight 00 00 01 02 01 01 
Hygienic 
Condition 
Good 14 28 09 18 23 23 
Moderate 30 60 27 54 57 57 
Poor 06 12 14 28 20 20 
Sleep Sound 32 64 26 52 58 58 
Disturbed 22 44 20 40 42 42 
Appetite Poor 35 70 42 84 77 77 
Good 15 30 06 12 21 21 
Excessive 00 00 02 04 02 02 
RESULTS 
Both the trial and control groups showed extremely 
significant result over subjective parameters. Trial 
drug Vajravatakmaņdurain group A was found more 
effective over the subjective parameters - weakness, 
palpitation, pallor and loss of appetite with % gain of 
39.77%, 39.39%, 39.17%, 38.09% respectively. (Figure 
1) 
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Statistical analysis between before and after 
treatment findings of objective parameters, extremely 
significant (P<0.0001) improvement was found in both 
groups in all parameters, except for RBC count in 
group A, which was significant with P value 0.0248. 
(Table 3) 
Table 3: Showing pattern of Hematological changes 




Mean SD SE P IP
T 































































































































































No unpleasant outcome of the trial drug was 
observed throughout the study. 
DISCUSSION  
Total 122 subjects were enrolled out of which 22 
subjects dropped out. Study was conducted on 100 
subjects. In both control group (Iron and Folic acid) 
and trial group (Vajravatakmaņdura) 50 subjects in 
each group completed the course of treatment. 
It was found that majority of subjects 74 (74%) were 
of mild anemia (Hb <11.5-10%). The prevalence 
among adolescent girls is well supported by previous 
studies.
[5]
 This study shows that mild variety of 
anemia is more prevalent among adolescent girls. 
Only 9 (9%) subjects were having severe anemia 
(Hb<8%). In these subjects with severe type of anemia 
other associated features were more prevalent and 
most of the subjects provided history of heavy 
bleeding during menstrual cycle.  
Thus, there no strong association of anemia was 
observed with menarche in the present study. Few 
studies reported no association between status of 




There was no any significant difference seen between 
different age groups because the age group range was 
very small. But it was observed that anemia was more 
prevalent  in adolescent girls aged between 14 to 15 




Adolescent girls are particularly prone to iron 
deficiency anemia because of increased demand of 
iron for hemoglobin, myoglobin and to make up the 




The trial drug (Vajravatakmaņdura
[12]
) possesses 
antioxidant, anti-inflammatory, bio-availability 
enhancing, anti-inflammatory, anti-helminthic 
properties and above all Mandura Bhasma which is a 
good hematinic, due to which extremely significant 
improvement was observed. (Table 4) 
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Table 4: Showing properties of ingredients of Trial 
Drug (Vajravatakmandura) 























Zingiberofficinale Anti-inflammatory, antitumour and 
antioxidant activities of ginger
[21] 










Terminalia chebula Antioxidant and radical scavenging 
abilities, compared to the 
standards.
[27] 





Antioxidant and radical scavenging 
abilities
[29] 









Cyperus rotundus Improving the small intestine 
absorption
[34] 
Hepatoprotective activity against 
CCl4 induced activity
[35] 





Nutritional anaemia is a major public health problem 
in India and is primarily due to iron deficiency 
especially in girls where they are exposed to risk of 
onset of menarche. Trial drug Vajravatakmaņdura 
showed almost equal and extremely significant 
improvement as compared to control drug IFA tablets. 
However Vajravatakmaņdura showed better results 
on all cardinal features except vertigo and irritability. 
Extremely significant improvement was observed in 
all objective parameters in both groups, except for 
RBC count in group A in which only significant 
improvement was found. In intergroup comparison all 
subjective and objective parameters showed non-
significant result. No adverse effects were reported 
during entire period of study by any of the patients in 
trial group treated with Vajravatakmaņdura. The trial 
drug Vajravatakmandoor is effective, safe and 
palatable for the management of iron deficiency 
anemia in adolescent girls. 
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